North America Smart Inhalers Market - Global Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2027

The North America smart inhalers market is expected to reach US$ 3,749.90 Mn in 2027 from US$ 503.91 Mn in 2018. The market is estimated to grow with a CAGR of 25.7% from 2019-2027.

North America Smart Inhalers Market The growth of the market is driven by the factors such as, growing geriatric population rising prevalence of COPD and asthma, along with rising awareness regarding the medical condition. However, the market is likely to get impacted due to risks associated with cyber threats limited knowledge regarding the use of smart inhalers.

North America Smart Inhalers Market The cases of asthma and COPD has been increasing across the globe at a significant rate. During recent years, there has been rise in the number of smokers as well as air pollution in developed as well as developing countries. Asthma is a non-communicable disease categorized by recurrent attacks of breathlessness and wheezing, which differ in severity and frequency from person to person. North America Smart Inhalers Market While an asthma attack occurs, the lining of the bronchial tubes swells, affecting the airways to narrow, hence limiting the flow of air into and out of the lungs. Recurrent asthma symptoms frequently lead to feeling of daytime fatigue, sleeplessness, reduced activity levels and school and work absence. As per estimates provided by the WHO, there are currently 235 million people suffering from asthma across the globe. As per the Centers for Disease Control and Prevention (CDC), the number of adults above 18 years of age currently having asthma are approximately 19 million in the United States, accounting for almost 7.7% of the total adult population.

📚 Download Sample PDF Copy@ https://www.businessmarketinsights.com/sample/TIPRE00006805

Similarly, there has been rising prevalence of COPD across the North America. North America Smart Inhalers Market Chronic obstructive pulmonary disease (COPD) is a progressive fatal lung disease that leads to breathlessness, leading to predisposes then exacerbations and later causes serious illness. As per the Global Burden of Disease Study report, a prevalence of around 251 million cases of COPD were recorded globally during the year 2016. North America Smart Inhalers Market It is estimated that globally approximately 3.17 million deaths were caused due to COPD during the year 2015, accounting for almost 5% of all deaths in 2015. North America Smart Inhalers Market The prevalence of COPD has been high in developed nations during the recent years. For instance, COPD is recognized as the third leading cause of death by disease in the United States. Approximately, 11 million individual are diagnosed with COPD. Hence, the rising prevalence of respiratory conditions such as asthma and COPD is anticipated to fuel the growth of the smart inhalers market across the globe at an exponential rate.

US is expected to lead the market in the North America region because the US has presence of various associations which provide help in the field of lung diseases. For instance, American Lung Association conducts research activities, education and training as well as undertakes initiatives to offer better treatment and support for the patients suffering with respiratory conditions such as asthma, COPD, influenza, lung cancer, pneumonia, and pulmonary fibrosis among others. North America Smart Inhalers Market Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.

📚Full Report Link @ https://www.businessmarketinsights.com/reports/north-america-smart-inhalers-market

The List of Companies

GlaxoSmithKline plc

Adherium Ltd.

Vectura Group plc

Novartis AG

Findair Sp. z o. o.

Cohero Health

Crux Product Design Ltd

Teva Pharmaceuticals

3M

Amiko Digital Health Limited

North America Smart Inhalers Market

North America Smart Inhalers Market The healthcare landscape is constantly evolving with innovations that improve patient outcomes and provide solutions for complex diseases. One such innovation is the introduction of smart inhalers, which have revolutionized the management of respiratory diseases. These inhalers, equipped with digital technology, have not only improved the way patients manage chronic conditions like asthma and chronic obstructive pulmonary disease (COPD), but they have also helped increase medication adherence, reduce hospitalizations, and enhance overall quality of life for individuals suffering from these diseases. In North America, smart inhalers have become a key part of respiratory care. This article explores the North American smart inhaler market, its drivers, trends, challenges, and the future outlook of the industry.

Limited Knowledge and Education Barriers
Another challenge hindering the widespread adoption of smart inhalers is the limited knowledge about their usage, particularly among patients and healthcare providers. While the concept of smart inhalers may be appealing, the complexity of technology can deter individuals who are not technologically savvy. Many patients, especially older adults, may struggle with setting up or understanding how to use the devices effectively. Additionally, healthcare professionals may not always be well-versed in the capabilities of these devices, hindering their ability to educate and guide patients.

To overcome this challenge, comprehensive patient education and training programs must be implemented. Patients need clear instructions on how to use their smart inhalers, interpret the data, and leverage the full benefits of the technology. Healthcare providers should also be equipped with the necessary knowledge and tools to educate patients about the proper use and advantages of these devices.

Furthermore, manufacturers of smart inhalers must focus on making their products as user-friendly as possible, with simple interfaces, easy-to-follow instructions, and adequate customer support. Making the devices intuitive and straightforward to use will ensure higher adoption rates and better outcomes for patients.

You can see this
North America Galacto Oligosaccharide Market- https://www.openpr.com/news/3925592/north-america-galacto-oligosaccharide-market-overview-top-key
North America RTD Alcoholic Beverages Market- https://www.openpr.com/news/3926211/north-america-rtd-alcoholic-beverages-market-by-key-players
North America Cancer Tissue Diagnostics Market- https://www.openpr.com/news/3925787/north-america-ceramic-balls-market-key-players-size-trends

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

This release was published on openPR.